Keyword: Stanford University
A team of Stanford University scientists has found a way to direct a regenerative diabetes medicine to the right cells more precisely.
Three patients with quadriplegia used a brain-computer interface to control a commercial tablet just by thinking about moving and clicking a cursor.
CuraSen Therapeutics has pulled off a $54.5 million series A funding round as it gains big-name backing to help tackle neurodegenerative disorders.
CRISPR-GO allows scientists to reorganize the genome—taking specific pieces and placing them at new locations in a cell’s nucleus.
A newly found stem cell can differentiate into just bone cells without the unwanted lineages found in previous cultures.
Machine learning identified mutations in 60 genes that raise the risk of abdominal aortic aneurysm (AAA).
RootPath raised $7 million to develop a T-cell therapy platform for cancer treatment that addresses the shortcomings of current technology.
One of the founding scientists of Illumina has come out with a new gene-sequencing software startup that aims to tackle antimicrobial resistance.
TG Therapeutics will fund and run early-phase clinical trials of the treatment for hematologic B-cell malignancies.
Stanford scientists are using CRISPR to model individual patients’ hearts and identify which gene variants raise their risk of sudden cardiac death.